CHOLESTEROL VALUES Initial Classification Based on Total Cholesterol and HDL Cholesterol Levels
Total Cholesterol:
- <200 mg/dl (5.2 mmol/L): Desirable blood cholesterol
- 200—239 mg/dl (5.2—6.2 mmol/L): Borderline – high blood cholesterol
- 240 mg/dl (6.2 mmol/L): High blood cholesterol
HDL Cholesterol:
- <35 mg/dl (0.9 mmol/L): Low HDL cholesterol
Treatment Decisions Based on LDL Cholesterol Level of 100 mg/dl (2.6 mmol/L)
Patient Category Initiation Level & LDL Goal Dietary Therapy:
- Without CHD and <2 RF: 160 mg/dl (4.1 mmol/L) & <160 mg/dl (4.1 mmol/L)
- Without CHD and e”2 RF: 130 mg/dL (3.4 mmol/L) & <130 mg/dL (3.4 mmo/L)
- With CHD: >100 mg/dL (2.6 mmol/L)
Drug Treatment & Goal of Treatment
- Without CHD and <2 RF: 190 mg/dL (4.9 mmol/L) & <160 mg/dL (4.1 mmol/L)
- Without CHD and e”2 RF: 160 mg/dl (4.1 mmol/L) & <130 mg/dl (3.4 mmol/L)
- With CHD: 130 mg/dL (3.4 mmol/L) & 100 mg.dL (2.6 mmol/L)
DIAGNOSIS OF DIABETES
- Fasting blood glucose >126
- Any glucose >200
- GTT: 2hrs >200
EFFUSIONS (PLEURAL/PERITONEAL) Exudate (IU/dl)
- Fluid LDH >200
- Fluid protein >3 g
- Fluid/serum LDH ratio >0.6
- Fluid/serum protein ratio <0.5
- Specific gravity >1.016
Transudate (IU/dl)
- Fluid LDH <200
- Fluid protein <3 g
- Fluid/serum LDH ratio <0.6
- Fluid/serum protein ratio >0.5
- Specific gravity <1.016
HYPERTENSION (JNC VII for Adults 18 yrs old)
- Normal: <120/<80
- Pre-hypertension: 120-139/80-89
- Stage 1: 140-159/90-99
- Stage 2: >160/>100
ACID-BASE DISORDERS Acid-base disorder/Initial change/Compensatory change/pH/Expected value range change
- Metabolic Acidosis: decreased HCO3/decreased PCO2/decreased pH/PCO2=1.5(HCO3)+8 (PCO2=last 2 digits of pH)
- Metabolic Alkalosis: increased HCO3/increased PCO2/increased pH/PCO2=0.9(HCO3) 9
- Respiratory Acidosis: increased PCO2/increased HCO3/decreased pH/acute: 10(PCO2)=0.08(pH) & chronic: 10(PCO2)= 0.03(pH)
- Respiratory Alkalosis: decreased PCO2/decreased HCO3/increased pH/acute: 10(PCO2)=0.08(pH) & chronic: 10(PCO2)=0.03(pH)
